IGF2BP1 and endometrial cancer: Recent studies revealed that IGF2BP1 bound to the 3’UTR m6A site of SOX2 mRNA and inhibited the degradation of SOX2 mRNA, which in turn led to the proliferation and metastasis of endometrial cancer cells [134].